Innate Pharma SA 6-K Filing
Ticker: IPHYF · Form: 6-K · Filed: Nov 10, 2025 · CIK: 1598599
| Field | Detail |
|---|---|
| Company | Innate Pharma SA (IPHYF) |
| Form Type | 6-K |
| Filed Date | Nov 10, 2025 |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
FAQ
What type of filing is this?
This is a 6-K filing submitted by Innate Pharma SA (ticker: IPHYF) to the SEC on Nov 10, 2025.
How long is this filing?
Innate Pharma SA's 6-K filing is 1 pages with approximately 268 words. Estimated reading time is 1 minutes.
Where can I view the full 6-K filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Stats: 268 words · 1 min read · ~1 pages · Grade level 10.6 · Accepted 2025-11-10 06:16:27
Filing Documents
- a2511106k-iphxincorporated.htm (6-K) — 10KB
- a251110exhibit991.htm (EX-99.1) — 20KB
- 0001628280-25-050768.txt ( ) — 32KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. INNATE PHARMA S.A. Date November 10, 2025 By s JONATHAN DICKINSON Name Jonathan Dickinson Title Chief Executive Officer